XRP has sharply declined against Bitcoin, losing nearly 8% of its value over the past week amid a broader cryptocurrency market downturn. The coin dropped 4.9% in the last 24 hours and is currently priced around $1.10. This decline is more severe than Bitcoin's 4.9% weekly drop and Ethereum's 7.4% loss. The market sell-off was intensified by a scandal involving Nvidia's CEO, which shook investor confidence and led to a drop in Nvidia shares. Despite the poor performance, some XRP community members remain optimistic, dismissing the crash as unrelated to XRP's fundamentals.
XRP's recent sharp decline against Bitcoin is context for readers following cryptocurrency trends. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 09, 2026 12:41 WIB: out of 50 priced major cryptocurrencies, 7 rose and 42 fell today. Notable movers include SNX at Rp2.857 with a 1-day change of -4.00%, FIL at Rp13.633 with -3.95%, and THETA at Rp2.512 with -3.57%.
argenx will acquire Unnatural Products (UNP) for $550 million upfront plus up to $600 million in milestones, totaling about $1.15 billion. UNP specializes in orally-delivered macrocyclic peptides targeting previously undruggable diseases, enhancing a...
Dapirolizumab pegol (DZP), an investigational biologic for systemic lupus erythematosus (SLE), demonstrated greater treatment response rates compared to placebo when combined with standard care in the Phase 3 PHOENYCS GO trial. Using a novel Treatmen...
Valneva announced positive Phase 2 trial results for its tetravalent Shigella vaccine candidate S4V2, showing a favorable safety profile and encouraging immune responses in infants and adults. The infant trial in Kenya demonstrated significant antibo...
Kraken has introduced native USDG stablecoin deposits and withdrawals on the Arbitrum One network as of October 29. This update allows users to fund their accounts more conveniently using USDG on Arbitrum One, expanding access to this stablecoin. The...
argenx announced it will acquire Unnatural Products, Inc. (UNP) for up to $1.15 billion, including upfront and milestone payments. This acquisition adds UNP's macrocyclic peptide discovery platform to argenx's antibody engineering capabilities, broad...
